Toyama, Japan

Isao Myoukan

This inventor holds 1 USPTO granted patent. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isao Myoukan. Retrieved from https://idiyas.com/inventor/isao-myoukan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Isao Myoukan

Introduction

Isao Myoukan is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His work is characterized by a focus on creating compounds that exhibit both efficacy and safety.

Latest Patents

Myoukan holds a patent for isoindole derivatives and salts thereof, which are represented by a specific general formula. This novel isoindole derivative demonstrates excellent antitumor activity while maintaining low toxicity, making it a promising candidate for cancer treatment.

Career Highlights

Myoukan is associated with Toyama Chemical Co., Ltd., where he has been instrumental in advancing research and development in medicinal chemistry. His innovative approach has led to the creation of compounds that could potentially improve patient outcomes in cancer therapy.

Collaborations

Throughout his career, Myoukan has collaborated with esteemed colleagues such as Takashi Nagai and Keishi Funaki. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Isao Myoukan's contributions to the field of pharmaceuticals, particularly through his patented isoindole derivatives, highlight his commitment to innovation in cancer treatment. His work continues to inspire advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…